Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells-Reference-Cited by-同舟云学术

Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells

Published:2017-04 Issue:4 Volume:25 Page:949-961
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

MacLeod Daniel T.,Antony Jeyaraj,Martin Aaron J.,Moser Rachel J.,Hekele Armin,Wetzel Keith J.,Brown Audrey E.,Triggiano Melissa A.,Hux Jo Ann,Pham Christina D.,Bartsevich Victor V.,Turner Caitlin A.,Lape Janel,Kirkland Samantha,Beard Clayton W.,Smith Jeff,Hirsch Matthew L.,Nicholson Michael G.,Jantz Derek,McCreedy Bruce

Funder

Research to Prevent Blindness

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Progress and prospects for engineered T cell therapies;Qasim;Br. J. Haematol.,2014

2. The basic principles of chimeric antigen receptor design;Sadelain;Cancer Discov.,2013

3. CD19-chimeric antigen receptor t cells for treatment of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia;Lorentzen;Scand. J. Immunol.,2015

4. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia;Porter;Sci. Transl. Med.,2015

5. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy;Best Practice & Research Clinical Haematology;2024-09

3. Allogeneic “Off-the-Shelf” CAR T cells: Challenges and advances;Best Practice & Research Clinical Haematology;2024-09

4. Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy;Frontiers in Immunology;2024-08-30

5. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28